184 related articles for article (PubMed ID: 29861382)
1. Clinical significance of the TNF-α receptors, TNFRSF2 and TNFRSF9, on cell migration molecules Fascin-1 and Versican in acute leukemia.
El Kramani N; Elsherbiny NM; El-Gayar AM; Ebrahim MA; Al-Gayyar MMH
Cytokine; 2018 Nov; 111():523-529. PubMed ID: 29861382
[TBL] [Abstract][Full Text] [Related]
2. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
3. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
4. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the cytoskeletal protein, Nestin, in acute leukemia.
Du X; Yang XH; Wu YF; Liang J; Zhang J; Huang ZC; Zhu ZP; Lin W; Zou MX; Wen JY; Wu SJ; Guo R; Zhang XM; Lahn BT; He F; Xiang AP
Biotech Histochem; 2015 Jul; 90(5):384-94. PubMed ID: 25839093
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
Badar T; Shetty A; Bueso-Ramos C; Cortes J; Konopleva M; Borthakur G; Pierce S; Huang X; Chen HC; Kadia T; Daver N; Dinardo C; O'Brien S; Garcia-Manero G; Kantarjian H; Ravandi F
Am J Hematol; 2015 Sep; 90(9):769-73. PubMed ID: 26017166
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee NY; Suh JS; Chae SC; Lee KS; Lee KB
Leuk Lymphoma; 2005 Jun; 46(6):885-91. PubMed ID: 16019534
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia.
Senda M; Fukuyama R; Nagasaka T
J Clin Pathol; 2016 Oct; 69(10):906-11. PubMed ID: 26951084
[TBL] [Abstract][Full Text] [Related]
11. [Plasma concentration of the shed form of L-selectin (sL-selectin) in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) and its relation to the clinical course].
Kapelko-Slowik K; Jaźwiec B; Mirosław S; Wołowiec D; Urbaniak-Kujda D; Tomaszewska-Toporska B; Potoczek S; Ciszak L; Kuliczkowski K
Pol Arch Med Wewn; 2004 Nov; 112(5):1283-8. PubMed ID: 15773509
[TBL] [Abstract][Full Text] [Related]
12. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
13. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
[TBL] [Abstract][Full Text] [Related]
14. Expression of 4-1BB and its ligand on blasts correlates with prognosis of patients with AML.
Schmohl JU; Nuebling T; Wild J; Kroell T; Kanz L; Salih HR; Schmetzer H
J Investig Med; 2016 Dec; 64(8):1252-1260. PubMed ID: 27388616
[TBL] [Abstract][Full Text] [Related]
15. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium.
Spertini O; Callegari P; Cordey AS; Hauert J; Joggi J; von Fliedner V; Schapira M
Blood; 1994 Aug; 84(4):1249-56. PubMed ID: 7519478
[TBL] [Abstract][Full Text] [Related]
16. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor Receptor Type 1-Associated Death Domain Protein Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia.
Xiao Y; Geng Z; Deng T; Wang D; Jiang L
Am J Med Sci; 2019 Feb; 357(2):111-115. PubMed ID: 30665491
[TBL] [Abstract][Full Text] [Related]
18. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
19. [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].
Kapelko-Słowik K; Wołowiec D; Sedek K; Jaźwiec B; Urbaniak-Kujda D; Kuliczkowski K
Pol Arch Med Wewn; 2002 Sep; 108(3):849-53. PubMed ID: 12600181
[TBL] [Abstract][Full Text] [Related]
20. Endocan, a potential prognostic and diagnostic biomarker of acute leukemia.
Xu Z; Zhang S; Zhou Q; Wang Y; Xia R
Mol Cell Biochem; 2014 Oct; 395(1-2):117-23. PubMed ID: 24934240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]